Zepp Health (ZEPP) Stock Chart & Stock Price History → [BUY ALERT] Our #1 A.I. Stock for March (From Behind the Markets) (Ad) Free ZEPP Stock Alerts $0.98 +0.06 (+6.52%) (As of 03/27/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Zepp Health Stock Price Performance5 Day Performance+2.08%1 Month Performance-19.67%3 Month Performance-35.10%6 Month Performance-16.95%Year-To-Date Performance-30.99%1 Year Performance-25.19% Receive ZEPP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Zepp Health and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the Markets[BUY ALERT] Our #1 A.I. Stock for MarchIt's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.Get the name of the stock here - before it takes off >>> ZEPP Stock Chart for Thursday, March, 28, 2024 ZEPP Chart by TradingView Zepp Health Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/27/2024$0.93$0.98+5.32%$1.04$0.9463,705 shs$60.10 million03/26/2024$0.92$0.93+1.14%$1.05$0.91180,865 shs$57.07 million03/25/2024$0.97$0.92-5.21%$0.97$0.90162,358 shs$56.42 million03/22/2024$1.08$0.96-11.11%$1.05$0.96108,785 shs$58.88 million03/21/2024$1.05$1.08+2.86%$1.08$1.0157,666 shs$66.24 million03/20/2024$1.07$1.05-1.87%$1.11$0.9774,488 shs$64.40 million Get the Latest News and Ratings for ZEPP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Zepp Health and its competitors with MarketBeat's FREE daily newsletter. 03/19/2024$1.22$1.07-12.30%$1.13$0.91348,433 shs$65.62 million03/18/2024$1.17$1.22+4.27%$1.22$1.1447,711 shs$74.83 million03/15/2024$1.15$1.15$1.19$1.1348,851 shs$70.53 million03/14/2024$1.21$1.15-4.56%$1.22$1.1363,431 shs$70.54 million03/13/2024$1.19$1.21+1.26%$1.25$1.1662,728 shs$73.90 million03/12/2024$1.13$1.19+5.31%$1.22$1.1544,903 shs$72.98 million03/11/2024$1.16$1.13-2.59%$1.22$1.1388,073 shs$69.30 million03/08/2024$1.16$1.16$1.19$1.1547,972 shs$71.14 million03/07/2024$1.17$1.16-0.85%$1.20$1.1558,348 shs$71.14 million03/06/2024$1.17$1.17$1.22$1.1736,580 shs$71.76 million03/05/2024$1.18$1.17-0.85%$1.22$1.1635,606 shs$71.76 million03/04/2024$1.23$1.18-4.07%$1.26$1.1673,403 shs$72.38 million03/01/2024$1.17$1.23+5.13%$1.29$1.1557,396 shs$75.44 million02/29/2024$1.19$1.17-1.68%$1.22$1.1582,084 shs$71.76 million02/28/2024$1.22$1.19-2.46%$1.22$1.1840,852 shs$72.98 million02/27/2024$1.19$1.22+2.52%$1.25$1.2028,832 shs$74.82 million02/26/2024$1.18$1.19+0.85%$1.28$1.16116,994 shs$72.98 million02/23/2024$1.26$1.18-6.35%$1.24$1.1854,036 shs$72.37 million02/22/2024$1.25$1.26+0.80%$1.30$1.2139,795 shs$77.28 million02/21/2024$1.19$1.25+5.04%$1.30$1.2058,787 shs$76.66 million02/20/2024$1.30$1.19-8.46%$1.31$1.1861,982 shs$72.98 million02/19/2024$1.30$1.30$1.34$1.2446,900 shs$79.74 million02/16/2024$1.32$1.30-1.52%$1.34$1.2446,903 shs$79.73 million02/15/2024$1.36$1.32-2.94%$1.39$1.2754,479 shs$80.96 million02/14/2024$1.28$1.36+6.25%$1.38$1.2744,698 shs$83.42 million02/13/2024$1.38$1.28-7.25%$1.36$1.2759,011 shs$78.50 million02/12/2024$1.23$1.38+12.20%$1.43$1.2691,419 shs$84.64 million02/09/2024$1.18$1.23+4.24%$1.30$1.1945,254 shs$75.44 million02/08/2024$1.28$1.18-7.81%$1.30$1.18110,149 shs$72.37 million02/07/2024$1.24$1.28+3.23%$1.28$1.2039,879 shs$78.50 million02/06/2024$1.18$1.24+5.08%$1.25$1.1865,316 shs$76.05 million02/05/2024$1.19$1.18-0.84%$1.24$1.1649,666 shs$72.37 million02/02/2024$1.20$1.20$1.25$1.1875,924 shs$73.60 million02/01/2024$1.22$1.20-1.64%$1.27$1.1563,627 shs$73.60 million[BUY ALERT] Our #1 A.I. Stock for March (Ad)It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.Get the name of the stock here - before it takes off >>>01/31/2024$1.25$1.22-2.40%$1.27$1.2146,965 shs$74.83 million01/30/2024$1.30$1.25-3.85%$1.30$1.2088,121 shs$76.66 million01/29/2024$1.40$1.30-7.14%$1.48$1.30101,923 shs$79.73 million01/26/2024$1.40$1.40$1.48$1.4055,796 shs$85.86 million01/25/2024$1.52$1.40-7.89%$1.57$1.4072,799 shs$85.86 million01/24/2024$1.60$1.52-5.00%$1.60$1.5256,881 shs$93.22 million01/23/2024$1.52$1.60+5.26%$1.60$1.5245,363 shs$98.13 million01/22/2024$1.60$1.52-5.00%$1.61$1.5046,597 shs$93.22 million01/19/2024$1.54$1.60+3.90%$1.60$1.4838,630 shs$98.13 million01/18/2024$1.52$1.54+1.32%$1.60$1.5045,780 shs$94.45 million01/17/2024$1.60$1.52-5.00%$1.60$1.5042,315 shs$93.22 million01/16/2024$1.60$1.60$1.75$1.6055,744 shs$98.13 million01/15/2024$1.60$1.60$1.80$1.6044,600 shs$98.14 million01/12/2024$1.75$1.60-8.57%$1.80$1.6044,700 shs$98.13 million01/11/2024$1.96$1.75-10.71%$2.10$1.73241,918 shs$107.34 million01/10/2024$1.58$1.96+24.05%$1.99$1.58224,245 shs$120.22 million01/09/2024$1.56$1.58+1.28%$1.65$1.5255,840 shs$96.90 million01/08/2024$1.47$1.56+6.12%$1.58$1.44156,219 shs$95.68 million01/05/2024$1.44$1.47+2.08%$1.49$1.4310,137 shs$90.16 million01/04/2024$1.39$1.44+3.60%$1.52$1.3937,301 shs$88.32 million01/03/2024$1.44$1.39-3.47%$1.43$1.3927,274 shs$85.25 million01/02/2024$1.42$1.44+1.41%$1.49$1.4237,213 shs$88.32 million01/01/2024$1.42$1.42$1.52$1.4067,000 shs$87.09 million12/29/2023$1.50$1.42-5.33%$1.52$1.4066,971 shs$87.09 million12/28/2023$1.51$1.50-0.66%$1.52$1.4579,655 shs$92.00 million12/27/2023$1.49$1.51+1.34%$1.52$1.4932,467 shs$92.61 million12/26/2023$1.44$1.49+3.47%$1.52$1.4295,831 shs$91.38 million Related Companies: Akerna Stock Price Chart Turnstone Biologics Stock Price Chart Assembly Biosciences Stock Price Chart MediciNova Stock Price Chart Cidara Therapeutics Stock Price Chart VolitionRx Stock Price Chart Kronos Bio Stock Price Chart Nutex Health Stock Price Chart Kezar Life Sciences Stock Price Chart Connect Biopharma Stock Price Chart Receive ZEPP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Zepp Health and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:ZEPP) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zepp Health Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.